Multimodal and spatially resolved profiling identifies distinct patterns of T-cell infiltration in nodal B-cell lymphoma entities

Summary T-cell-engaging immunotherapies have improved the treatment of nodal B-cell lymphoma, but responses vary highly. Future improvements of such therapies require better understanding of the variety of lymphoma-infiltrating T-cells. We employed single-cell RNA and T-cell receptor sequencing alongside quantification of surface proteins, flow cytometry and multiplexed immunofluorescence on 101 lymph nodes from healthy controls, and patients with diffuse large B-cell, mantle cell, follicular, or marginal zone lymphoma. This multimodal resource revealed entity-specific quantitative and spatial aberrations of the T-cell microenvironment. Clonal PD1+ TCF7− but not PD1+ TCF7+ cytotoxic T-cells converged into terminally exhausted T-cells, the proportions of which were variable across entities and linked to inferior prognosis. In follicular and marginal zone lymphoma, we observed expansion of follicular helper and IKZF3+ regulatory T-cells, which were clonally related and inversely associated with tumor grading. Overall, we portray lymphoma-infiltrating T-cells with unprecedented comprehensiveness and decipher both beneficial and adverse dimensions of T-cell response.

[1]  Garry P. Nolan,et al.  A real-time GPU-accelerated parallelized image processor for large-scale multiplexed fluorescence microscopy data , 2022, Frontiers in Immunology.

[2]  C. Flowers,et al.  Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression , 2022, Blood cancer discovery.

[3]  Nathan E. Reticker-Flynn,et al.  Identification of cell types in multiplexed in situ images by combining protein expression and spatial information using CELESTA , 2022, Nature Methods.

[4]  Wendy J. Fantl,et al.  CellSeg: a robust, pre-trained nucleus segmentation and pixel quantification software for highly multiplexed fluorescence images , 2022, BMC Bioinformatics.

[5]  Xueda Hu,et al.  Pan-cancer single-cell landscape of tumor-infiltrating T cells , 2021, Science.

[6]  L. Sehn,et al.  Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Kersten,et al.  Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma. , 2021, The New England journal of medicine.

[8]  E. Giné,et al.  Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma , 2021, The Journal of clinical investigation.

[9]  G. Nolan,et al.  Multicellular modules as clinical diagnostic and therapeutic targets , 2021, Trends in Cancer.

[10]  E. Campo,et al.  Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity. , 2021, Immunity.

[11]  G. Nolan,et al.  Annotation of Spatially Resolved Single-cell Data with STELLAR , 2021, bioRxiv.

[12]  S. Dietrich,et al.  Processing human lymph node samples for single-cell assays , 2021, STAR protocols.

[13]  W. Huber,et al.  An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodies , 2021, Blood advances.

[14]  Ansuman T. Satpathy,et al.  Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer , 2021, bioRxiv.

[15]  G. Nolan,et al.  Strategies for Accurate Cell Type Identification in CODEX Multiplexed Imaging Data , 2021, Frontiers in Immunology.

[16]  Ansuman T. Satpathy,et al.  High-throughput and single-cell T cell receptor sequencing technologies , 2021, Nature Methods.

[17]  G. Nolan,et al.  CODEX multiplexed tissue imaging with DNA-conjugated antibodies , 2021, Nature Protocols.

[18]  Ludmila V. Danilova,et al.  Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade , 2021, Science.

[19]  S. Raychaudhuri,et al.  Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment, and disease , 2021, Nature Immunology.

[20]  Santiago J. Carmona,et al.  UCell: Robust and scalable single-cell gene signature scoring , 2021, bioRxiv.

[21]  L. Xerri,et al.  Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade. , 2021, Blood advances.

[22]  G. Salles,et al.  Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Hanlee P. Ji,et al.  Single Cell Analysis Can Define Distinct Evolution of Tumor Sites in Follicular Lymphoma. , 2021, Blood.

[24]  W. Klapper,et al.  Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma. , 2021, Blood.

[25]  Aaron M. Streets,et al.  Joint probabilistic modeling of single-cell multi-omic data with totalVI , 2021, Nature Methods.

[26]  Q. Zhai,et al.  Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma , 2020, Journal of immunology research.

[27]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[28]  C. Weyand,et al.  The Transcription Factor TCF1 in T Cell Differentiation and Aging , 2020, International journal of molecular sciences.

[29]  J. Leonard,et al.  Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma. , 2020, Blood.

[30]  Salil S. Bhate,et al.  Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front , 2020, Cell.

[31]  Yoshiya Tanaka,et al.  Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin‐2 Through Transcriptional Regulation in Systemic Lupus Erythematosus , 2020, Arthritis & rheumatology.

[32]  S. Fröhling,et al.  Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels , 2020, Nature Cell Biology.

[33]  J. Cyster,et al.  T follicular helper cells in germinal center B cell selection and lymphomagenesis , 2020, Immunological reviews.

[34]  S. Raychaudhuri,et al.  Multimodal single-cell approaches shed light on T cell heterogeneity. , 2019, Current opinion in immunology.

[35]  K. Gu,et al.  Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count , 2019, BMC Cancer.

[36]  E. Wherry,et al.  Defining ‘T cell exhaustion’ , 2019, Nature Reviews Immunology.

[37]  Salil S. Bhate,et al.  Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front , 2019, Cell.

[38]  Itay Tirosh,et al.  Single-Cell RNA Sequencing in Cancer: Lessons Learned and Emerging Challenges. , 2019, Molecular cell.

[39]  Ash A. Alizadeh,et al.  Determining cell-type abundance and expression from bulk tissues with digital cytometry , 2019, Nature Biotechnology.

[40]  Noemi Andor,et al.  Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints. , 2019, Blood.

[41]  F. Hodi,et al.  Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade , 2019, Nature Immunology.

[42]  M. Shipp,et al.  Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Daniel E. Speiser,et al.  Intratumoral Tcf1+PD‐1+CD8+ T Cells with Stem‐like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy , 2019, Immunity.

[44]  L. Ni,et al.  High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells , 2018, Front. Immunol..

[45]  Etienne Becht,et al.  Reverse-engineering flow-cytometry gating strategies for phenotypic labelling and high-performance cell sorting , 2018, bioRxiv.

[46]  Stefano Monti,et al.  Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes , 2018, Nature Medicine.

[47]  Roland Schmitz,et al.  Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma , 2018, The New England journal of medicine.

[48]  Fabian J Theis,et al.  SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.

[49]  Charles E. Cook,et al.  A call for public archives for biological image data , 2018, Nature Methods.

[50]  W. Shi,et al.  Transcription Factor IRF4 Promotes CD8+ T Cell Exhaustion and Limits the Development of Memory‐like T Cells during Chronic Infection , 2017, Immunity.

[51]  W. Klapper,et al.  Obinutuzumab for the First‐Line Treatment of Follicular Lymphoma , 2017, The New England journal of medicine.

[52]  R. Martin,et al.  Integrated STAT3 and Ikaros Zinc Finger Transcription Factor Activities Regulate Bcl-6 Expression in CD4+ Th Cells , 2017, The Journal of Immunology.

[53]  Hannah A. Pliner,et al.  Reversed graph embedding resolves complex single-cell trajectories , 2017, Nature Methods.

[54]  R. Satija,et al.  Single-cell RNA sequencing to explore immune cell heterogeneity , 2017, Nature Reviews Immunology.

[55]  H. Swerdlow,et al.  Large-scale simultaneous measurement of epitopes and transcriptomes in single cells , 2017, Nature Methods.

[56]  J. Aerts,et al.  SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.

[57]  Hyo Jin Kim,et al.  Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma , 2017, Oncotarget.

[58]  L. Pasqualucci,et al.  The genetics of nodal marginal zone lymphoma. , 2016, Blood.

[59]  A. Sharpe,et al.  T follicular regulatory cells , 2016, Immunological reviews.

[60]  Charles H. Yoon,et al.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.

[61]  Ryan D. Morin,et al.  Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas , 2015, Clinical Cancer Research.

[62]  E. Wherry,et al.  Molecular and cellular insights into T cell exhaustion , 2015, Nature Reviews Immunology.

[63]  D. Valmori,et al.  Differential expression of the immunosuppressive enzyme IL4I1 in human induced Aiolos+, but not natural Helios+, FOXP3+ Treg cells , 2015, European journal of immunology.

[64]  R. Gascoyne,et al.  The tumour microenvironment in B cell lymphomas , 2014, Nature Reviews Cancer.

[65]  A. Salar,et al.  Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation , 2014, Leukemia.

[66]  Cole Trapnell,et al.  The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells , 2014, Nature Biotechnology.

[67]  I. Zlobec,et al.  Proper paraffin slide storage is crucial for translational research projects involving immunohistochemistry stains , 2014, Clinical and Translational Medicine.

[68]  R. Bosselut,et al.  Faculty Opinions recommendation of Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. , 2014 .

[69]  D. Heo,et al.  An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone , 2014, Leukemia & lymphoma.

[70]  M. Calaminici,et al.  Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma , 2013, Nature Genetics.

[71]  Manel Juan,et al.  Landscape of somatic mutations and clonal evolution in mantle cell lymphoma , 2013, Proceedings of the National Academy of Sciences.

[72]  Y. Belkaid,et al.  Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells , 2010, The Journal of Immunology.

[73]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[74]  E. Wherry,et al.  A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. , 2009, Immunity.

[75]  E. Sebzda,et al.  Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns , 2008, Nature Immunology.

[76]  S. Ansell,et al.  CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells. , 2007, Blood.

[77]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[78]  J. Friedman Greedy function approximation: A gradient boosting machine. , 2001 .

[79]  Jason G. Cyster,et al.  A chemokine-driven positive feedback loop organizes lymphoid follicles , 2000, Nature.

[80]  A. Purohit,et al.  A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. , 1993, Journal of immunology.

[81]  R. Negrin,et al.  Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T‐regulatory cells , 2009, International journal of cancer.